Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 424B5 Offering Prospectus
  2. 424B5 Offering Prospectus
  3. 424B5 Offering Prospectus
  4. 424B5 Offering Prospectus
  5. 424B5 Offering Prospectus
  6. 424B5 Offering Prospectus
  7. UPLOAD Other SEC-generated Letter
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. UPLOAD Other SEC-generated Letter
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. 424B4 Offering Prospectus
  13. S-1/A Offering Registration Statement
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. S-1/A Offering Registration Statement
  18. UPLOAD Other SEC-generated Letter
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 1 of 2 · 23 filings